Kane Biotech Inc. (KNBIF)
KNBIF Stock Price Chart
Explore Kane Biotech Inc. interactive price chart. Choose custom timeframes to analyze KNBIF price movements and trends.
KNBIF Company Profile
Discover essential business fundamentals and corporate details for Kane Biotech Inc. (KNBIF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 Aug 2007
Employees
—
Website
https://kanebiotech.comCEO
Robert B. Huizinga CNeph(C), MSc(Epi), R.N., RN NNC
Description
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
KNBIF Financial Timeline
Browse a chronological timeline of Kane Biotech Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 May 2026
Upcoming earnings on 27 May 2026
Upcoming earnings on 4 Sept 2025
Earnings released on 27 Aug 2025
Earnings released on 28 Apr 2025
EPS came in at -$0.01 , while revenue for the quarter reached $289.66K .
Earnings released on 28 Mar 2025
Earnings released on 26 Nov 2024
EPS came in at -$0.00 , while revenue for the quarter reached $945.18K .
Earnings released on 29 Aug 2024
EPS came in at $0.04 , while revenue for the quarter reached $453.80K .
Earnings released on 23 May 2024
EPS came in at -$0.01 , while revenue for the quarter reached $38.21K .
Earnings released on 26 Mar 2024
EPS came in at -$0.56 , while revenue for the quarter reached -$949.78K .
Earnings released on 28 Nov 2023
EPS came in at -$0.01 , while revenue for the quarter reached $529.98K .
Earnings released on 29 Aug 2023
EPS came in at -$0.01 , while revenue for the quarter reached $496.19K .
Earnings released on 25 May 2023
EPS came in at -$0.01 , while revenue for the quarter reached $500.77K .
Earnings released on 27 Mar 2023
EPS came in at -$0.01 , while revenue for the quarter reached $515.47K .
Earnings released on 24 Nov 2022
EPS came in at -$0.01 , while revenue for the quarter reached $417.46K .
Earnings released on 25 Aug 2022
EPS came in at -$0.01 , while revenue for the quarter reached $651.81K .
Earnings released on 26 May 2022
EPS came in at -$0.01 , while revenue for the quarter reached $452.27K .
Earnings released on 24 Mar 2022
EPS came in at -$0.01 , while revenue for the quarter reached $322.86K .
Earnings released on 16 Nov 2021
EPS came in at -$0.01 , while revenue for the quarter reached $224.88K .
Earnings released on 30 Sept 2021
EPS came in at -$0.01 , while revenue for the quarter reached $426.98K .
Earnings released on 27 May 2021
EPS came in at -$0.01 , while revenue for the quarter reached $299.18K .
Earnings released on 25 Mar 2021
EPS came in at -$0.01 , while revenue for the quarter reached $270.86K .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 , while revenue for the quarter reached $201.59K .
KNBIF Stock Performance
Access detailed KNBIF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.